Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Equity Ratio (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Equity Ratio data on record, last reported at 0.07 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 89.0% year-over-year to 0.07; the TTM value through Dec 2025 reached 0.07, up 89.0%, while the annual FY2025 figure was 0.07, 89.0% up from the prior year.
  • Equity Ratio reached 0.07 in Q4 2025 per PTCT's latest filing, down from 0.06 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.14 in Q1 2021 and bottomed at 0.64 in Q4 2024.
  • Average Equity Ratio over 5 years is 0.22, with a median of 0.12 recorded in 2022.
  • Peak YoY movement for Equity Ratio: tumbled 27526.0% in 2022, then skyrocketed 89.71% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.0 in 2021, then crashed by 27526.0% to 0.2 in 2022, then tumbled by 112.19% to 0.43 in 2023, then crashed by 49.15% to 0.64 in 2024, then skyrocketed by 89.0% to 0.07 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.07 in Q4 2025, 0.06 in Q3 2025, and 0.08 in Q2 2025.